IOVANCE BIOTHERAPEUTICS INC (IOVA)

US4622601007 - Common Stock

7.65  -0.14 (-1.8%)

After market: 7.65 0 (0%)

Free users can only see 4 years or quarters

Examples of complete financials are available for MSFT and AAPL.

Please register or login for additional data.

TTM
(2024-9-30)
2023
(2023-12-31)
2022
(2022-12-31)
2021
(2021-12-31)
2020
(2020-12-31)
Revenue
90.86M1.19M0.000.000.00
Cost Of Goods
77.45M10.76MN/AN/AN/A
Gross Profit
13.40M-9.57MN/AN/AN/A
Operating Expenses
443.36M450.99M398.88M342.70M261.94M
Research and Development
297.58M344.08M294.78M259.04M201.73M
Selling, General, and Administrative Expenses
145.78M106.92M104.10M83.66M60.21M
Operating Income
-429.96M-460.56M-398.88M-342.70M-261.94M
Interest Income/Expense
13.82M13.04M2.99M450.00K2.36M
Income Before Taxes
-416.14M-447.52M-395.89M-342.25M-259.58M
Income Tax
-6.14M-3.48MN/AN/AN/A
Net Income
-410.00M-444.04M-395.89M-342.25M-259.58M
EBITDA
-398.45M-439.14M-389.57M-339.59M-260.80M
 
Per Share Data
EPS Diluted Total Ops
-1.50-1.89-2.49-2.23-1.88
Non GAAP EPS
-1.49-1.88-2.48-2.22-1.89
 
Statistics
Gross Profit Margin
14.75%-804.54%N/AN/AN/A
Profit Margin
-451.25%-37345.42%N/AN/AN/A
Operating Profit Margin
-473.22%-38734.99%N/AN/AN/A

All data in USD

Charts